Inhibition of miR‐181a effectively reverses Aβo‐induced impairments in plasticity and memory deficits in primary hippocampal cultures and 3xTg‐AD mice through restoration of GluA2 and GluA1 protein levels in the hippocampus. The gene discussed is ABO; the disease is Alzheimer disease.